Clinical Trials Browser

INDUSTRY × toripalimab × Tumor-Agnostic × Clear all

NCT04991506 2025-06-23

A Study of ES102 (OX40 Agonist) in Combination With JS001 in Patients With Advanced Solid Tumors

Phase 1 Completed

Neoplasms

NCT05615974 2024-12-19

A Phase I/II Study of LM-101 Injection in Patients With Advanced Malignant Tumors

Phase 1/2 Recruiting

Neoplasms

NCT06389526 2024-09-19

A Study of CHS-1000 in Participants With Advanced or Metastatic Solid Tumors

Phase 1 Not yet recruiting

Neoplasms